Aviance Capital Partners LLC Trims Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Aviance Capital Partners LLC decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,415 shares of the medical equipment provider’s stock after selling 200 shares during the period. Aviance Capital Partners LLC’s holdings in Intuitive Surgical were worth $695,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. International Assets Investment Management LLC grew its position in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after acquiring an additional 1,088,415 shares during the period. Capital Research Global Investors purchased a new position in shares of Intuitive Surgical during the 1st quarter worth $374,390,000. Strategic Financial Concepts LLC increased its position in shares of Intuitive Surgical by 40,221.4% during the 2nd quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock worth $1,184,000 after purchasing an additional 265,461 shares during the last quarter. Canada Pension Plan Investment Board raised its holdings in Intuitive Surgical by 36.4% in the 1st quarter. Canada Pension Plan Investment Board now owns 807,780 shares of the medical equipment provider’s stock valued at $322,377,000 after buying an additional 215,444 shares during the period. Finally, Manning & Napier Advisors LLC acquired a new position in Intuitive Surgical in the second quarter valued at about $91,466,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Truist Financial boosted their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Leerink Partners upped their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Stifel Nicolaus increased their target price on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $524.61.

Intuitive Surgical Stock Performance

ISRG opened at $538.82 on Wednesday. The stock has a market capitalization of $191.92 billion, a P/E ratio of 86.63, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $304.50 and a one year high of $544.38. The business’s 50-day simple moving average is $501.42 and its 200-day simple moving average is $460.69.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. This represents a 93.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 91,178 shares of company stock valued at $45,897,071. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.